Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
University Hospital, Clermont-Ferrand
AstraZeneca
Context Therapeutics Inc.
Indiana University
BioNTech SE
Memorial Sloan Kettering Cancer Center
Loma Linda University
City of Hope Medical Center
University of Nebraska
Vastra Gotaland Region
Cantonal Hospital of St. Gallen